Filing Flows

Filing Flows › Surgery Partners (SGRY) › Q1 2026 › vs Q1 2025

Surgery Partners (SGRY) Q1 2026 vs Q1 2025 (year over year)

Surgery Partners's revenue rose $34.9M (+4%) from $776M in Q1 2025 to $811M in Q1 2026. The biggest changes: Patient service revenues +$34.3M (+5%); Other +$600K (+4%).

Surgery Partners, Q1 2026: revenue $811M (+4% year over year), operating margin 8.1%, net loss $2.1M, operating cash flow $11.7M. The chart draws each line against Q1 2025, the increases inside each band.

Surgery Partners: what changed, Q1 2026 vs Q1 2025Surgery Partners: what changed, Q1 2026 vs Q1 2025Costs & expenses$37.9MPatient service revenues$34.3MOperating costs$31.0MGovernment$28.9MOther operating costs$27.7MNegative free cash flow (OCF …−$12.4MWorking capital & other−$7.1MInterest & other, net$6.9MCapital expenditures−$6.7MOperating cash flow$5.7M

Every line

LineQ1 2026Q1 2025Change%
Private insurance$399M$394M$5.1M+1%
Government$357M$328M$28.9M+9%
Self-pay$19.2M$20.1M−$900K-4%
Other service revenues$18.8M$17.6M$1.2M+7%
Patient service revenues$794M$760M$34.3M+5%
Other$16.6M$16.0M$600K+4%
Revenue$811M$776M$34.9M+4%
Income tax benefit$1.2M$0$1.2M—
Net loss$2.1M$300K$1.8M+600%
Costs & expenses$814M$776M$37.9M+5%
Operating costs$745M$714M$31.0M+4%
Interest & other, net$69.1M$62.2M$6.9M+11%
General & admin$39.3M$36.0M$3.3M+9%
Other operating costs$706M$678M$27.7M+4%
Operating cash sources$44.3M$43.9M$400K+0.9%
Depreciation & amortization$38.5M$36.3M$2.2M+6%
Share-based compensation$5.8M$7.6M−$1.8M-24%
Net loss absorbed$2.1M$300K$1.8M+600%
Working capital & other$30.5M$37.6M−$7.1M-19%
Operating cash flow$11.7M$6.0M$5.7M+95%
Capital expenditures$16.0M$22.7M−$6.7M-30%
Negative free cash flow (OCF − capex)$4.3M$16.7M−$12.4M-74%

Questions

How much did Surgery Partners's revenue grow year over year in Q1 2026?

Surgery Partners's revenue rose $34.9M (+4%) from $776M in Q1 2025 to $811M in Q1 2026.

What drove Surgery Partners's revenue change in Q1 2026?

Patient service revenues +$34.3M (+5%); Other +$600K (+4%).

Q1 2026 results → · Compare in the interactive Sankey →